Insights & Resources

Discover how outsourcing in pharmaceutical manufacturing enhances quality, ensures compliance and mitigates risks in a rapidly evolving industry.

Several updates to HB 8 will affect Texas community colleges and their state funding. Here’s the breakdown and how they will affect campuses.

Learn how HMRC's guidelines impact transfer pricing for life sciences and other multinationals and how to mitigate risks and ensure compliance.

Within the changing landscape of educational technology, schools face new risk factors that affect students, faculty and administrators.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

KPMG has released their 2024 biopharma report detailing the challenges and opportunities for pharma companies moving forward into the new year.

Weaver’s Chief Talent Officer, Linc Ashby, gives his insights on those qualities of a leader that set both companies and teams up for success.

The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.

The biopharma industry has experienced a resurgence the first part of 2024. J.P. Morgan’s Q2 report shares critical insights into the future of the industry.

PCI DSS sets the standard for payment card security in higher education detailing compliance levels, reporting requirements and strategies to protect data.

Ensure your school district's financial transparency and compliance. Discover strategies to avoid common deficiencies in AFR and ACFR reviews.